Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?

被引：67

作者：

Livermore, DM ^{[1
]}

机构：

[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2000年 / 46卷 / 03期

关键词：

D O I：

10.1093/jac/46.3.347

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：347 / 350

页数：4

共 50 条

[1] Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology
Wesson, KM
Lerner, D
Silverberg, NB
Weinberg, JM
CLINICS IN DERMATOLOGY, 2003, 21 (01) : 64 - 69
[2] Quinupristin-dalfopristin and linezolid: Evidence and opinion
Eliopoulos, GM
CLINICAL INFECTIOUS DISEASES, 2003, 36 (04) : 473 - 481
[3] Linezolid is active in vitro against quinupristin/dalfopristin resistant enterococci and staphylococci
Siddiqui, F
Peterson, LR
Noskin, GA
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1179 - 1179
[4] In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci
Tünger, A
Aydemir, S
Uluer, S
Cilli, F
INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 120 (06) : 546 - 552
[5] In vitro antibiotic susceptibilities of ocular isolates to quinupristin/dalfopristin (Synercid®) and linezolid (Zyvox®).
Kresloff, M
Shah, M
Ritterband, D
Shapiro, D
Intal, M
McCormick, S
Seedor, J
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S253 - S253
[6] Effect of linezolid and quinupristin/dalfopristin on formation and disruption of Staphylococcus haemolyticus biofilm in vitro
Juda, M.
Helon, P.
Malm, A.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S145 - S145
[7] Susceptibility of vancomycin-resistant enterococcus faecium (VREF) to linezolid and quinupristin/dalfopristin
McLeroth, PL
Sordillo, EM
Polsky, B
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1178 - 1178
[8] Use of quinupristin/dalfopristin and linezolid in the treatment of vancomycin-resistant enterococcal (VRE) infections since FDA approval
Lai, KK
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1178 - 1178
[9] In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
El-Azizi M.
Rao S.
Kanchanapoom T.
Khardori N.
Annals of Clinical Microbiology and Antimicrobials, 4 (1)
[10] Antibiotics for gram-positive bacterial infections - Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid
Lundstrom, TS
Sobel, JD
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2000, 14 (02) : 463 - +

← 1 2 3 4 5 →